News Daily News Anatomic Disease After PCI Linked With Worse Outcomes: VA CART Michael O'Riordan December 22, 2022
News Daily News Reduction in BP Drives Treatment Preference for Hypertensive Patients Michael O'Riordan December 20, 2022
News Daily News Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths Michael O'Riordan December 08, 2022
News Features Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI? L.A. McKeown December 02, 2022
News Daily News Think Before You Shake: UK Biobank Data Link Added Salt to Long-term CVD Risks L.A. McKeown November 30, 2022
News Daily News Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis Michael O'Riordan November 22, 2022
News Daily News Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study Michael O'Riordan November 18, 2022
News Conference News Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices L.A. McKeown November 18, 2022
News Conference News AHA 2022 Partial Oral Antibiotic Regimen for Endocarditis Effective in Real World Michael O'Riordan November 10, 2022
News Conference News AHA 2022 New Tool Assesses Risk in Acute HF Then Suggests Next Steps, Cutting Later Events Yael L. Maxwell November 07, 2022
News Conference News AHA 2022 Common ‘Heart’ Supplements Can’t Beat Statins: SPORT Michael O'Riordan November 06, 2022
News Conference News VIVA 2022 TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years L.A. McKeown November 03, 2022
News Daily News More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials Michael O'Riordan October 28, 2022
News Daily News SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes Michael O'Riordan October 18, 2022
News Conference News TCT 2022 Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year L.A. McKeown September 23, 2022
News Daily News Most Patient-Reported Outcome Measures in CVD Fall Short L.A. McKeown September 23, 2022
News Conference News TCT 2022 Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes Todd Neale September 22, 2022
News Conference News TCT 2022 SCAAR Registry Delves Into Left Main Revascularization Outcomes Michael O'Riordan September 19, 2022